All Articles

As cyber threats and system failures loom, a new class of secure hardware access tools promises to slash IT recovery time from days to mere minutes.

Lawn care giant O.M. Scott & Sons launches H2HOSE, a canned water inspired by backyard hoses. Is this a brilliant play on nostalgia or a brand extension too far?

Yellowstone Bourbon’s 2026 release blends 14-year-old bourbon with a dual-port cask finish, targeting collectors and conscious consumers alike.

A new integration between Rogo and Snowflake solves the biggest AI problem for finance: using proprietary data without compromising security or governance.

As enterprises grapple with AI's 'black box' problem, a quiet shift is underway. A new architecture promises auditable, deterministic automation.

A new deal between Goody, Wet Brush, and a youth softball league shows a shift in sponsorship—investing in athlete confidence, not just brand visibility.

Terret unveils Nexus, an AI platform that promises not just to find sales problems, but to fix them. Is this the dawn of the autonomous revenue engine?

A first-of-its-kind benchmark reveals that top AI models fail at interpreting human nuance, posing major risks as 60% of managers use them for career decisions.

As AI-powered crime surges, Alloy reports major growth by deploying autonomous "agentic AI" to continuously vet customers and automate compliance work.

With a $2M NIH grant, a San Diego biotech is using AI to find the 'on switches' in our DNA, a breakthrough that could make future therapies more potent.

By monetizing empty lots while securing spots for their own drivers, trucking firms are using a new marketplace model to solve a national parking crisis.

A new partnership embeds discounted pet insurance into leasing software, signaling a shift from simple pet tolerance to strategic, tech-driven resident support.

Genasys extends its loan maturity, but at a steep price: a 20% guaranteed return for its lender. Is this a savvy move to fuel growth or a risky bet?

As Corrixr's novel CRISPR therapy nears human trials, the appointment of Seagen veteran Nancy Whiting signals a strategic shift from lab to market.

A construction firm's radical shift to critical minerals, guided by a military strategist, reveals a new front in the race for America's resource security.

With a Parkinson's therapy in hand and a universal AI model, Cellular Intelligence adds seasoned leaders to turn biological ambition into durable value.

Slate Medicines appoints Mark W. Hahn, a CFO known for steering biotechs to massive acquisitions, signaling a major strategic push for its next-gen therapy.

After a 90% stock crash since its IPO, activist firm Randian Capital is demanding a strategic review, questioning leadership and industry headwinds.

Serial investor Gary Vaynerchuk takes an equity stake in agency Paul Street, signaling a seismic shift in how premium brands approach partnerships.

Octave Intelligence is moving beyond AI hype with CoLabs, an ambitious program embedding its experts with clients like Bechtel to build real-world AI solutions.